Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Donald James Jurgens
Observed names:
D Jurgens,
D. J. Jurgens,
D. Jurgens,
Donald J Jurgens,
Donald J. Jurgens
Institution:
CentraCare Health System
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Mayo Clinic,
Michigan Cancer Research Consortium,
Illinois CancerCare,
CentraCare Health System
OpenAlex ID:
A5071511348
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1
2009
·
Charles L. Loprinzi
, Rui Qin
, et al.
·
Journal of Clinical Oncology
·
165
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
2019
·
Kathleen M Mullane
, Vicki A Morrison
, et al.
·
The Lancet Infectious Diseases
·
37
Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia.
2004
·
Donald J Jurgens
, Alvaro Moreno-Aspitia
, et al.
·
PubMed
·
34
Anagrelide-Associated Cardiomyopathy in Polycythemia Vera and Essential Thrombocythemia.
2004
·
Donald J. Jurgens
, Alvaro Moreno-Aspitia
, et al.
·
Blood
·
17
Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG 3506 (STEEL).
2024
·
Edwin Melencio Posadas
, Hiram Alberto Gay
, et al.
·
Journal of Clinical Oncology
·
8
Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG 3506 (STEEL).
2024
·
Edwin Melencio Posadas
, Hiram Alberto Gay
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Pregabalin for hot flashes in women: NCCTG trial N07C1
2009
·
C. L. Loprinzi
, R. Qin
, et al.
·
Journal of Clinical Oncology
·
2
A randomized phase 2 study of enhanced AR blockade with enzalutamide in high-risk patients with biochemical relapse undergoing salvage radiation: Final results from RTOG 3506 (STEEL).
2026
·
Edwin Melencio Posadas
, Hiram Alberto Gay
, et al.
·
Journal of Clinical Oncology
·
1
PDF
A Randomized Phase II Study of Enhanced AR Blockade with Enzalutamide in High-Risk Patients with Biochemical Relapse Undergoing Salvage Radiation: Final Results from RTOG 3506 (STEEL)
2026
·
E. Posadas
, H.A. Gay
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
9
Citation count:
266
H-index:
5
I10-index:
4
Year
Topic
Type